Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.
Acute Hepatitis B
Chronic Hepatitis B
Hepatitis B
Pregnancy
Journal
Hepatology international
ISSN: 1936-0541
Titre abrégé: Hepatol Int
Pays: United States
ID NLM: 101304009
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
11
08
2021
accepted:
06
12
2021
pubmed:
4
2
2022
medline:
20
4
2022
entrez:
3
2
2022
Statut:
ppublish
Résumé
Hepatitis B virus (HBV) infection still remains a major public health issue in the Asia-Pacific region. Most of the burden of HBV-related disease results from infections acquired in infancy through perinatal or early childhood exposure to HBV in Asia-Pacific. Hepatitis B during pregnancy presents unique management issues for both the mother and fetus. These APASL guidelines provide a comprehensive review and recommendations based on available evidence in the literature, for the management of females with HBV infection through every stage of pregnancy and postpartum. These also address the concerns, management challenges, and required follow-up of children born to hepatitis B-positive mothers.
Identifiants
pubmed: 35113359
doi: 10.1007/s12072-021-10285-5
pii: 10.1007/s12072-021-10285-5
doi:
Substances chimiques
Hepatitis B e Antigens
0
Types de publication
Editorial
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
211-253Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2022. Asian Pacific Association for the Study of the Liver.
Références
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
doi: 10.1136/bmj.328.7454.1490
Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia–Pacific region: a Lancet Gastroenterology and Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167–228
doi: 10.1016/S2468-1253(19)30342-5
World Health Organization. Operationalizing elimination of mother-to-child transmission of Hepatitis B virus in the Western Pacific Region. World Health Organization Regional Office for the Western Pacific, Manila, Licence: CC BY-NC-SA 3.0 IGO. 2021
World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. World Health Organization, Geneva. 2016. ( http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ )
https://www.globalhep.org/country-data-dashboards
https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html
Esaulenko V, Lyalina LV, Trifonov GF, Pokrovsky VI, Totolyan AA. Viral hepatitis in the Russian Federation. Analytical review. Issue 10/E. SPb: FBUN NIIEM named after Pasteur, 2016. 152 (In Russian)
Ganina AA, Kyuregyan KK, Mikhaylov MI. Detection rate of hepatitis among pregnant female screened for TORCH-infections medical alphabet No. 19/2016. Volume No. 3 Modern Laboratory. 41. https://www.elibrary.ru/item.asp?id=29992553 (In Russian)
Belopolskaya MA, Avrutin VY, Ostankova YV, Dmitrieva MI, Rukoiatkina EA, Dmitriev AV, Kalinina OV. Modern trends and problems of hepatitis B in pregnant womenin St-Petersburg: prevalence and genetic variants of virus. HIV Infect Immunosuppr 2017; 9(4). https://hiv.bmoc-spb.ru/jour/article/view/305/281 . (In Russian)
Kovaleva TA. Chronic viral hepatitis B and C during pregnancy: clinical and epidemiological, psychosocial, pathogenetic aspects. 2017; 327. https://www.dissercat.com/content/khronicheskie-virusnye-gepatity-v-i-s-v-period-beremennosti-kliniko-epidemiologicheskie-psik . (In Russian)
Köse Ş, Gül S, Tatar B, Temur M, Göl B. HBV, HCV and HAV seroprevalence in pregnant women admitted to İzmir Aegean Obstetrics and Gynecology Training and Research Hospital: 2010–2011 İzmir Ege Doğumevi ve Kadın Hastalıkları Eğitim ve Araştırma Hastanesi’ne başvuran gebe kadınlarda HBV, HCV ve HAV seroprevalansları: 2010–2011. Turk Hij Den Biyol Derg 2017; 74(1): 21–28. Doi: https://doi.org/10.5505/TurkHijyen.2016.39259
Nersesov AV, Berkinbayev SF, Junusbekova GA, Jumabayeva AE, Novitskaya MS, Kyanysh N. Prevalence of viral hepatitis among residents of South Kazakhstan region. Medicine (Almaty). 2016;171(9):30–33 (In Russian)
Azimova SM, Odinaev RI Chronic hepatitis “B” in pregnant women. Bull Acad Sci Repub Tajikistan. Department of Biological and Medical Sciences. 2015; 2:89–93 (In Russian)
https://aua.am/chsr/PDF/2000/HepatitB_FINAL.pdf
Agayev S, Geleishvili M, Rush T, Maes E. Evaluation of surveillance system for hepatitis B in pregnant women in Baku, Azerbaijan. 2009. https://www.tephinet.org/evaluation-of-surveillance-system-for-hepatitis-b-in-pregnant-women-in-baku-azerbaijan-may-2009-%E2%80%93
Khachatryan S, Vanyan A, Sahakyan G. Hepatitis B immunoprophylaxis in Armenia. Blood. 2015;2(20):53
Aminzadeh Z, Gachkar L, Sayyadi Anari AR. Frequency of HBsAg positive in pregnant womenRafsanjan in the year 2003. J Rafsanjan Univ Med Sci. 2004;3(2):126–133 (Persian)
Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011;11(9):736–739
doi: 10.5812/kowsar.1735143X.1965
Motamedifar M, Amini E, Talezadeh Shirazi P, Sarvari J. The prevalence of HBsAgandHBsAbamongpregnantwomenre-ferring to Zeinabiyeh Hospital, Shiraz Iran. Shiraz E Med J. 2012;13(4):187–196
Motazakker M, Shokat Nagadeh M, Khalili F, Shayeri B. Hepatitis B virus infection among pregnant women attending health care centers of Urmia. J Uilan Univ Med Sci. 2014;23(89):45–50 (Persian)
Shoghli A, Nabavi SM, Alavian SM, Kolifarhood G, Goya MM, Namazi R, et al. Hepatitis B surface antigen prevalence in pregnant women: a cross-sectional survey in Iran. Int J Prev Med. 2014;5(Suppl 3):S213–S218
Mobin AR, Mohammadian F, Mazloomzadeh S, Esmaeilzadeh A, Sorouri Zanjani R, Savabi S, et al. Seroprevalence of Hepatitis B virus among pregnant women referred to healthcare centers of Zanjan. Zanjan Univ Mes Sci J. 2014;22(93):96–104 (Persian)
Kavosi A, Vizvari P, Mohammadi G, Jouybari L, Sanagu A. Seroprevalence of positive HbsAg and its associated factors in pregnantwomen referred to health centers of Agh-Ghala city in 2010–2012. Iran J Obstet Gynecol Infertil. 2015;18(149):8–16 (Persian)
Kheiri L, Makvandi S. The prevalence of hepatitis B surface antigen (HBsAg) and its influencing factors in pregnant women referring to Healthcare Centers of Dehloran, Iran in 2011–2012. J Midwifery Reprod Health. 2015;3(3):424–429
Afzali H, Momen Heravi M, Moravveji SA, Poorrahnama M. Prevalence of hepatitis B surface antigen in pregnant women in Beheshti Hospital of Kashan, Isfahan. Iran Red Crescent Med J. 2015;17(7):e20598
doi: 10.5812/ircmj.20598v2
Bayani M, Biazar T, Bayani F, Siadati S. The effect of hepatitis B vaccination at birth on reducing the prevalence of hepatitis B surface antigen among rural pregnant women in Babol, Iran. J Babol Univ Med Sci. 2016;18(1):7–10
Malekifar P, Babanejad M, Izadi N, Alavian SM. The frequency of HBsAg in pregnant women from eastern mediterranean and Middle Eastern countries: a systematic review and meta-analysis. Hepat Mon. 2018;18(9):e58830
Mahdi BM, Saour M, Abdulrazzaq HI. Evaluation of hepatitis B virus infection in pregnant women. Int J Biomed Res. 2015;6(06):379–381
doi: 10.7439/ijbr.v6i6.2103
Ali SS, Salman BR. Seroprevalence of Hepatitis B surface antigen among pregnant women visiting primary health centers in Baghdad Al-jadeda sector in Baghdad. J Fac Med Baghdad. 2018;60(1):43–46
doi: 10.32007/jfacmedbagdad.v60i1.43
Zamir C, Dagan R, Zamir D, et al. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers. Pediatr Infect Dis J. 1999;18(Suppl. 3):262–266
doi: 10.1097/00006454-199903000-00011
Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as independent risk factor for adverse perinatal outcome. Liver Int. 2010;30:765–770
doi: 10.1111/j.1478-3231.2010.02218.x
Abu Freha N, Wainstock T, Menachem TN, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status and long-term endocrine morbidity of the offspring-a population-based cohort study. J Clin Med. 2020;9(3):796
doi: 10.3390/jcm9030796
Batayneh N, Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol. 2002;10(3):127–132
doi: 10.1155/S1064744902000121
Othman B, Al-Najjar MAA, Othman D, Al-Qudah R, Basheti I. Prevalence, knowledge of and attitude towards hepatitis B virus among pregnant females in Jordan. J Viral Hepat. 2020;27(11):1108–1118
doi: 10.1111/jvh.13342
Madi N, Al-Tawalah H, Abdul Khalik D, Al-Nakib W. A relatively high number of pregnant women in kuwait remain susceptible to rubella: a need for an alternative vaccination policy. Med Princ Pract. 2014;23:145–148
doi: 10.1159/000356892
Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, Al Amiry A, et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006;52:202–206
doi: 10.1016/j.jinf.2005.05.006
Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdi YS, Mishkhas A, Bakhsh M, et al. Serosurvey of hepatitis B surface antigen in pregnant Saudi women. East Mediterr Health J. 2005;11(4):640–647
Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus seroprevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol. 2008;14(2):70–72
doi: 10.4103/1319-3767.39621
Bani I, Mahfouz MS, Gaffar EMA, Elhassan I, Yassin AO, Ageely HM. Prevalence and risk factors of hepatitis B virus among pregnant women in Jazan Region-Kingdom of Saudi Arabia. J Biol Agric Healthc. 2012;2(8):45–48
Yalçın Bahat P, Turan G, Yüksel Özgör B, Bağcı ÇK. Comparison of hepatitis B, hepatitis C, and HIV seropositivity of Syrian and Turkish pregnant women. Turk J Obstet Gynecol. 2019;16(2):95–99
doi: 10.4274/tjod.galenos.2019.15564
Evirgen Ö, Aksakal M, Melek I, Önlem Y, Sabahattin O. Seropositivity of hepatitis B and hepatitis C in women who were admitted to Hatay Maternityand Children’s Hospital. Viral Hepat Derg. 2010;16(2):111–116
Yavuzcan A, Altınbas A, Altınbas S. An unexpected low Hepatitis B seroprevalence in pregnant women from the rural Southeastern Turkey. Afr J Microbiol Res. 2011;5(23):3942–3945
doi: 10.5897/AJMR11.675
Gönen I. The frequency of HBV and HCV in pregnant women in rural areas. Viral Hepat Derg. 2011;17(2):66–68
Deveci O. Investigation of intrauterine transmission of hepatitis B Virus to children from HBsAg-positive pregnant women. J Microbiol Infect Dis. 2011;1(1):14–16
doi: 10.5799/ahinjs.02.2011.01.0004
Balık G, Üstüner I, Kagıtcı M, Ural UM, Tekin YB, Sentürk S. HBsAg, antiHBs and anti-HCV seroprevalance in pregnant women living in Rize region. Dicle Med J. 2013;40(2):254–257
Aynioglu A, Aynioglu Ö, Tarik A, Aydin M, Altunok ES. HBsAg, anti-HBs and anti-HCV seropositivity rates among pregnant women attending a University Hospital in Zonguldak. Viral Hepat J. 2015;21(1):31–34
doi: 10.4274/vhd.73792
Dogan K, Guraslan H, Ozel G, Aydan Z, Yasar L. Seroprevalence rates of Toxoplasma gondii, rubella, cytomegalovirus, syphilis, and hepatitis B, seroprevalences rate in the pregnant population in Istanbul. Turk Parazitol Derg. 2014;38(4):228–233 (Turkish)
doi: 10.5152/tpd.2014.3435
Guckan R, Kilinc C, Gozdemir E. HBSAG, anti Hbs, anti -HCV and anti -HIV seroplevalence in pregnant women living. Asian Pac J Nurs. 2016;3(1):9–12
Furuncuoglu Y, Bolukbas FF, Bolukbas C, Torun P, Ozturk R. Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation. Postgrad Med J. 2016;92(1091):510–513
doi: 10.1136/postgradmedj-2015-133876
Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana’a, Yemen. BMC Pregnancy Childbirth. 2013;13:127
doi: 10.1186/1471-2393-13-127
Chen CT. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission. Lancet Gastroenterol Hepatol. 2018;3(9):598–599
doi: 10.1016/S2468-1253(18)30198-5
Zheng H, Cui FQ, Wang FZ, et al. The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China. J Viral Hepat. 2018;25(1):88–96
doi: 10.1111/jvh.12757
Wang Y, Zhou H, Zhang L, et al. Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci Rep. 2017;7(1):12090
doi: 10.1038/s41598-017-12005-2
Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study. J Viral Hepat. 2018;25(4):401–411
doi: 10.1111/jvh.12829
Zhang L, Wang YY, Huang YJ, et al. Status of HBsAg seroprevalence in 15 million rural couples in China: a cross-sectional study. Sci Rep. 2017;7:42822
doi: 10.1038/srep42822
Xin X, Wang Y, Cheng J, et al. Seroepidemiological survey of hepatitis B virus infection among 764,460 women of childbearing age in rural China: a cross-sectional study. J Clin Virol. 2016;81:47–52
doi: 10.1016/j.jcv.2016.05.014
Evans AA, Cohen C, Huang P, et al. Prevention of perinatal hepatitis B transmission in Haimen City, China: results of a community public health initiative. Vaccine. 2015;33(26):3010–3015
doi: 10.1016/j.vaccine.2015.01.054
Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013;10:17
doi: 10.1186/1743-422X-10-17
Zhang L, Gui X, Wang B, et al. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission. Eur J Pediatr. 2014;173(9):1161–1168
doi: 10.1007/s00431-014-2305-7
Wang F, Zhang G, Zheng H, et al. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine. 2017;35(33):4229–4235
doi: 10.1016/j.vaccine.2017.06.019
Chen T, Wang J, Qiu H, et al. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(−): epidemiological data from Shaanxi, China. Medicine (Baltimore). 2018;97(27):e11406
doi: 10.1097/MD.0000000000011406
Sheng QJ, Wang SJ, Wu YY, Dou XG, Ding Y. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: an observational study. Medicine (Baltimore). 2018;97(22):e10931
doi: 10.1097/MD.0000000000010931
Dashtseren B, Bungert A, Bat-Ulzii P, Enkhbat M, Lkhagva-Ochir O, Jargalsaikhan G, et al. Endemic prevalence of hepatitis B and C in Mongolia: a nationwide survey amongst Mongolian adults. J Viral Hepat. 2017;24(9):759–767
doi: 10.1111/jvh.12697
Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. Progress toward hepatitis B control and elimination of mother-to-child transmission of hepatitis B virus—Western Pacific Region, 2005–2017. MMWR Morb Mortal Wkly Rep. 2019;68:195–200
doi: 10.15585/mmwr.mm6808a2
Cho EJ, Kim SE, Suk KT, et al. Current status and strategies for hepatitis B control in Korea. Clin Mol Hepatol. 2017;23(3):205–211
doi: 10.3350/cmh.2017.0104
Hur YJ, Choe SA, Choe YJ, Paek J. Hepatitis B surface antigen and antibody positivity among women of childbearing age after three decades of universal vaccination in South Korea. Int J Infect Dis. 2020;104:551–555
doi: 10.1016/j.ijid.2020.11.147
Kim JH, Kim JS, Lee JJ, et al. Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital. Korean J Intern Med. 2014;29(3):307–314
doi: 10.3904/kjim.2014.29.3.307
Sugiyama A, Ohisa M, Nagashima S, Yamamoto C, Chuon C, Fujii T, et al. Reduced prevalence of hepatitis B surface antigen positivity among pregnant women born after the national implementation of immunoprophylaxis for babies born to hepatitis B virus-carrier mothers in Japan. Hepatol Res. 2017;47(12):1329–1334
doi: 10.1111/hepr.12943
Chen DS. Fighting against viral hepatitis: lessons from Taiwan. Hepatology. 2011;54:381–392
doi: 10.1002/hep.24500
CDC. Center for disease control, Taiwan 2015 national various immunization completion rate. 2017. http://www.cdc.gov.tw/professional/page.aspx?treeid=5b0231beb94edffc&nowtreeid=3D1CDC342B28E123
Su WJ, Chen SF, Yang CH, Chuang PH, Chang HF, Chang MH. The impact of universal infant hepatitis B immunization on reducing the hepatitis B carrier rate in pregnant women. J Infect Dis. 2019;220:1118–1126
doi: 10.1093/infdis/jiy706
Ork V, Woodring J, Shafiqul Hossain M, et al. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Vaccine. 2019;37:5059–5066
doi: 10.1016/j.vaccine.2019.06.073
Minta AA, Silva MWT, Shrestha A, et al. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018. Vaccine. 2021;39:1982–1989
doi: 10.1016/j.vaccine.2021.02.042
Sebastian VJ, Bhattacharya S, Ray S, Daud JH. Prevalence of hepatitis-B surface antigen in the pregnant women of Brunei Darussalam. Southeast Asian J Trop Med Public Health. 1990;21:123–127
Htwe O, Coates PD, Krasu M, Tju H, Soe NN, Tan C, et al. Prevalence of hepatitis B and other infections among pregnant women seen in a referral centre in Brunei Darussalam. Brunei Int Med J. 2013;9(4):220–226
Gunardi H, Zaimi LF, Soedjatmiko AR, Muljono DH. Current prevalence of hepatitis B infection among parturient women in Jakarta, Indonesia. Acta Med Indones. 2014;46:3–9
Muljono HD. Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepatogastroenterol. 2017;7(1):55–59
Girawan D, Judistiani RTD, Risan NA, Bestari MB, Nugraha ES, Ermaya YS, et al. The high prevalence of negative hepatitis B surface antibody (Anti-HBs) among pregnant women in bandung, indonesia: a community-based study. Int J Hepatol. 2020;19(2020):3414869
Norizuki M, Kitamura T, Komada K, et al. Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic. BMC Infect Dis. 2019;19:1–9
doi: 10.1186/s12879-019-4086-0
Xeuatvongsa A, Komada K, Kitamura T, et al. Chronic hepatitis B prevalence among children and mothers: results from a nationwide, population-based survey in Lao People’s Democratic Republic. PLoS ONE. 2014;9:e88829
doi: 10.1371/journal.pone.0088829
Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, et al. Hepatitis B virus in the Lao People’s Democratic Republic: a cross sectional serosurvey in different cohorts. BMC Infect Dis. 2014;14:457
doi: 10.1186/1471-2334-14-457
Choisy M, Keomalaphet S, Xaydalasouk K, Quet F, Latthaphasavang V, Buisson Y. Prevalence of hepatitis B virus infection among pregnant women attending antenatal clinics in Vientiane, Laos, 2008–2014. Hepat Res Treat. 2017;2017:1–5
doi: 10.1155/2017/1284273
Shamsuddin K, Marmuji LZ. Weighted analysis of prevalence and risk factors of hepatitis B infection among antenatal mothers in Ipoh. Singap Med J. 2010;51:800–805
Bierhoff M, Angkurawaranon C, Myat Min A, Gilder ME, Win Tun N, Keereevijitt A, et al. Maternal hepatitis B infection burden, comorbidity and pregnancy outcome in a low-income population on the myanmar-thailand border: a retrospective cohort study. J Pregnancy. 2019;25(2019):8435019
Carpio GCA, Taguba AQ, Tan LCQ, Ong JP, Daez MLO. Prevalence and risk factors of hepatitis B infection in pregnant women at the prenatal clinic of the university of the Philippines—Philippine General Hospital. Int Dig Dis Forum Hong Kong Electron Only Abstr. 2015;13(7):E83
Mendoza IT, Jose SM. The association of chronic hepatitis B infectivity with fetomaternal outcome: a retrospective cohort study in a tertiary hospital. PJOG. 2020;44(2):16–24
Thamkhantho M, Chayachinda C. Characteristics, prevalence, and HBeAg correlation of hepatitis B in pregnancy: a siriraj hospital experience. J Med Assoc Thailand. 2020;103:276–280
Hall C, Gibbons M, Murphy D, Nourse C. Prevalence of hepatitis B infection in women delivering at a community health centre in Dili, Timor-Leste and discussion of programmatic challenges. Trans R Soc Trop Med Hyg. 2015;109(4):280–282
doi: 10.1093/trstmh/tru207
Miyakawa M, Yoshida L-M, Nguyen H-AT, et al. Hepatitis B virus infection among pregnant mothers and children after the introduction of the universal vaccination program in Central Vietnam. Sci Rep. 2021;11:8676
doi: 10.1038/s41598-021-87860-1
Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, Nguyen BT, et al. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS ONE. 2012;7(6):e39027
doi: 10.1371/journal.pone.0039027
Nguyen VTT, Trang HTQ, Ishikawa N, Anh Nguyen L, Anh LAK, Minh TB, et al. Feasibility, benefits, and cost-effectiveness of adding universal hepatitis B and syphilis testing to routine antenatal care services in Thai Nguyen province, Vietnam. Int J Std Aids. 2021;32(2):135–143
doi: 10.1177/0956462420953722
Akhter S, Talukder MQ, Bhuiyan N, Chowdhury TA, Islam MN, Begum S. Hepatitis B virus infection in pregnant mothers and its transmission to infants. Indian J Pediatr. 1992;59(4):411–415
doi: 10.1007/BF02751551
Karim Rumi MA, Begum K, Sawkat Hassan M, Munir Hasan SM, Golam Azam M, Nadim Hasan K, et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: Implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg. 1998;59(2):318–322
doi: 10.4269/ajtmh.1998.59.318
Shamsuzzaman M, Singhasivanon P, Kaewkungwal J, Lawpoolsri S, Tangkijvanich P, Gibbons RV, et al. Hepatitis B among pregnant women attending health care facilities in rural Bangladesh. Southeast Asian J Trop Med Public Health. 2011;42(6):1410–1413
Nayak NC, Panda SK, Bhan MK, Guha DK, Zuckerman AJ. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol [Internet]. 1987;21(2):137–145
doi: 10.1002/jmv.1890210205
Abass F, Thomas RD, Rajkumar A, Gupta N, Puliyel JM. Controlling perinatally acquired hepatitis B [Internet]. Indian J Pediatr. 2001;9:365
doi: 10.1007/BF02721853
Sandesh K, Varghese T, Harikumar R, Beena P, Sasidharan VP, Bindu CS, et al. Prevalence of hepatitis B and C in the normal population and high risk groups in north Kerala. Trop Gastroenterol. 2006;27(2):80–83
Pande C, Sarin SK, Patra S, Bhutia K, Mishra SK, Pahuja S, et al. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol. 2011;83(6):962–967
doi: 10.1002/jmv.22017
Naveira MCM, Badal K, Dhakal J, Mayer NA, Pokharel B, Del Prado RF. Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017). Hepatol Med Policy. 2018;3(1):1–17
doi: 10.1186/s41124-017-0031-2
Shedain PR, Baral G, Sharma KR, Dhital S, Devkota MD. Prevalence and mother-to-newborn transmission of hepatitis B Virus in Tertiary Care Hospital in Nepal. J Nepal Health Res Counc. 2019;17(3):278–284
doi: 10.33314/jnhrc.v17i3.1636
Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HUR. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010;16(Suppl):S15-23
doi: 10.26719/2010.16.Supp.15
Ali M, Idrees M, Ali L, Hussain A, Ur Rehman I, Saleem S, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011;6(8):102
doi: 10.1186/1743-422X-8-102
Ahmad A, Khichi GQ, Rehman A. Hepatitis B markers Professional. Med J. 2007;1:307–311
Yousfani S, Mumtaz F, Memon A, Memon MA, Sikandar R. Antenatal screening for hepatitis B and C virus carrier state at a university hospital. JLUMHS. 2006;5:24–27
Hakeem A, Khan MS, Abdullah M, Rehman A, Hashmi MI. Prevalence of HbsAg AND anti HCV in pregnant ladies attending antenatal clinic at Sheikh Zayed Medical Complex, Rahim Yar Khan. Esculapio. 2006;2:6–8
Sheikh SM. Hepatitis B and C: value of universal antenatal screening. J Coll Phys Surg Pak. 2009;19(3):179–182
Khattak ST, Ali Marwat M, Khattak IU, Khan TM, Naheed T. Comparison of frequency of hepatitis B and hepatitis C in pregnant women in urban and rural area of district Swat. J Ayud Med Coll Abbottabad. 2009;21(2):12–15
Ahmad I. Prevalence of Hepatitis B and C Viral Infection Among Pregnant Women in Peshawar, Pakistan. Hepat Mon. 2016;16(6):e36383
doi: 10.5812/hepatmon.36383
Jamil A, Hamid S, Aziz Q, Asim M. Prevalence of hepatitis B among pregnant women. JIMDC. 2018;7(2):128–131
Howell J, Pedrana A, Cowie BC, Doyle J, Getahun A, Ward J, et al. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: where are we now and barriers to meeting World Health Organization targets by 2030. J Gastroenterol Hepatol. 2019;34(1):40–48
doi: 10.1111/jgh.14457
Howell J, Balderson G, Hellard M, et al. The increasing burden of potentially preventable liver disease among adult liver transplant recipients: a comparative analysis of liver transplant indication by era in Australia and New Zealand. J Gastroenterol Hepatol. 2016;31:434–441
doi: 10.1111/jgh.13082
Graham S, Guy RJ, Cowie B, et al. Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis. BMC Infect Dis. 2013;13:403
doi: 10.1186/1471-2334-13-403
Bergin H, Wood G, Walker SP, Hui L. Perinatal management of hepatitis B virus: clinical implementation of updated Australasian management guidelines. Obstet Med. 2018;11(1):23–27
doi: 10.1177/1753495X17731990
O’Sullivan BG, Gidding H, Law MG, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis b virus infection in Australia in 2000. Aust N Z J Public Health. 2004;28:212–216
doi: 10.1111/j.1467-842X.2004.tb00697.x
Guirgis M, Zekry A, Yan K, Bu YM, Lee A. Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes. J Gastroenterol Hepatol. 2009;24(6):998–1001
doi: 10.1111/j.1440-1746.2009.05841.x
Giles ML, Davey MA, Wallace EM. Chronic hepatitis B infection and the risk of gestational diabetes: a cross-sectional study. BJOG. 2020;127(9):1147–1152
doi: 10.1111/1471-0528.16217
Robinson T, Bullen C, Humphries W, Hornell J, Moyes C. The New Zealand hepatitis B screening programme: screening coverage and prevalence of chronic hepatitisB infection. N Z Med J. 2005;118:U1345
Addidle M. Impact of universal hepatitis B vaccination on antenatal hepatitis B prevalence in the Midlands region of the North Island New Zealand. N Z Med J. 2011;124(1332):40–44
WHO: Country cooperation strategy at a glance: Pacific Island countries. 2011. http://wpro.who.int/en
Lee AU, Mair L, Kevin B, Gandi L, Tarumuri O, Lee C, et al. Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea. West Pac Surveill Response J. 2020;11(4):6–9
doi: 10.5365/wpsar.2020.11.3.001
Bauduceau O, Berlioz A, Buisson Y. Hepatites B, C et E en Nouvelle-Calédonie. Etude séro-épidémiologique chez les appelés du contingent. Hepatitis B, C, and E in New Caledonia Seroepidemiologic study in military recruits. Med Trop (Mars). 2000;60(2):167–170 (French)
Berlioz-Arthaud A, Perolat P, Buisson Y. 10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia). Vaccine. 2003;21(21–22):2737–2742
doi: 10.1016/S0264-410X(03)00226-3
Wilson N, Ruff TA, Rana BJ, Leydon J, Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine. 2000;18:3059–3066
doi: 10.1016/S0264-410X(00)00080-3
Tuinakelo LR, Tayler-Smith K, Khogali M, Marks GB. Prevalence of anaemia, syphilis and hepatitis B in pregnant women in Nausori, Fiji. Public Health Action. 2013;3(1):72–75
doi: 10.5588/pha.12.0069
Abara WE, Cha S, Malik T, DeSimone MS, Schillie S, Collier M, et al. Prenatal screening for and prevalence of hepatitis B surface antigen in pregnant women and prevention of transmission to infants born to infected mothers-guam, 2014. J Pediatr Infect Dis Soc. 2018;7(4):290–295
doi: 10.1093/jpids/pix062
World Health Organization. Regional Office for the Western Pacific. Prevalence surveys of sexually transmitted infections among seafarers and women attending antenatal clinics in Kiribati: 2002–2003. WHO Regional Office for the Western Pacific, Manila. 2004. https://apps.who.int/iris/handle/10665/206930
Fischer G, Wang S, Ahring S, Fowler K, Hainline S, Chinglong M, et al. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net. Pediatr Infect Dis J. 2009;28(7):593–597
doi: 10.1097/INF.0b013e318196bf5c
Ménard D. Toxoplasmose, rubéole, tréponématoses, hépatite virale B et infection par le VIH chez les femmes suivies pour grossesse de la population de la côte Est de Nouvelle-Calédonie [Toxoplasmosis, rubella, syphilis, hepatitis B and HIV infection in women being followed for pregnancy in a population on the east coast of New Caledonia]. Bull Soc Pathol Exot. 2001;94(5):403–405
https://www.aidsdatahub.org/sites/default/files/resource/sgs-antenatal-women-youth-solomon-islands-2008.pdf
Getahun A, Baekalia M, Panda N, Lee A, Puiahi E, Khan S, et al. Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015. World J Hepatol. 2016;8(34):1521–1528
doi: 10.4254/wjh.v8.i34.1521
Han YT, Sun C, Liu CX, Xie SS, Xiao D, Liu L, et al. Clinical features and outcome of acute hepatitis B in pregnancy. BMC Infect Dis. 2014;14:368
doi: 10.1186/1471-2334-14-368
Ratnam D, Visvanathan K. New concepts in the immunopathogenesis of Chronic hepatitis B: the importance of the innate immune response. Hepatol Int. 2008;2(1):12–18
doi: 10.1007/s12072-008-9067-0
Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29(Suppl 1):133–139
doi: 10.1111/j.1478-3231.2008.01933.x
Mohite BJ, Rath S, Bal V, Kamat SA, Marathe SN, Zuckerman AJ, et al. Mechanisms of liver cell damage in acute hepatitis B. J Med Virol. 1987;22(3):199–210
doi: 10.1002/jmv.1890220302
Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau DT, et al. Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B. J Clin Gastroenterol. 2018;52:255-261.106–110
doi: 10.1097/MCG.0000000000000822
Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, et al. Total alanine aminotransferase (ALT) flares in pregnant North American women with chronic hepatitis B infection: results from a prospective observational study. Am J Gastroenterol. 2019;114:1283–1291
doi: 10.14309/ajg.0000000000000221
Lin HH, Wu WY, Kao JH, Chen DS. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol. 2006;21:605–609
doi: 10.1111/j.1440-1746.2006.04198.x
La Rocca C, Carbone F, Longobardi S, Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014;162:41–48
doi: 10.1016/j.imlet.2014.06.013
Li L, Wang L, Huang C, Diao L, Zhang Y, Zhang X, et al. Chronic hepatitis B infection alters peripheral immune response in women with reproductive failure. Am J Reprod Immunol. 2019;81:e13083
doi: 10.1111/aji.13083
Singhal A, Kanagala R, Jalil S, Wright HI, Kohli V. Chronic HBV with pregnancy: reactivation flare causing fulminant hepatic failure. Ann Hepatol. 2011;10:233–236
doi: 10.1016/S1665-2681(19)31575-3
Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003;18:246–252
doi: 10.1046/j.1440-1746.2003.02976.x
Wong F, Pai R, Van Schalkwyk J, Yoshida EM. Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis. Ann Hepatol. 2014;13:187–195
doi: 10.1016/S1665-2681(19)30881-6
Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA. 1990;87:6599–6603
doi: 10.1073/pnas.87.17.6599
Tian Y, Kuo CF, Akbari O, Ou JH. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44:1204–1214
doi: 10.1016/j.immuni.2016.04.008
Bai G, Wang Y, Zhang L, Tang Y, Fu F. The study on the role of hepatitis B virus X protein and apoptosis in HBV intrauterine infection. Arch Gynecol Obstet. 2012;285:943–949
doi: 10.1007/s00404-011-2096-2
Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67:20–26
doi: 10.1002/jmv.2187
Foaud H, Maklad S, Mahmoud F, El-Karaksy H. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection. 2015;43(3):307–314
doi: 10.1007/s15010-015-0733-6
Inui A, Komatsu H, Sogo T, Nagai T, Abe K, Fujisawa T. Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus. J Med Virol. 2007;79:670–675
doi: 10.1002/jmv.20884
Liu SL, Dong Y, Zhang L, Li MW, Wo J, Lu LW, et al. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Arch Virol. 2009;154:437–443
doi: 10.1007/s00705-009-0315-y
Papadakis MA, Elefsiniotis IS, Vlahos G, Daskalakis G, Barbatis C, Antsaklis A. Intrauterine-transplacental transmission of hepatitis B virus (HBV) from hepatitis B e antigen negative (precore mutant, G1896A) chronic HBV infected mothers to their infants Preliminary results of a prospective study. J Clin Virol. 2007;38:181–183
doi: 10.1016/j.jcv.2006.10.008
Cheng H, Su H, Wang S, Shao Z, Men K, Li M, et al. Association between genomic heterogeneity of hepatitis B virus and intrauterine infection. Virology. 2009;387:168–175
doi: 10.1016/j.virol.2009.02.015
Vyas AK, Sharma BC, Sarin SK, Trehanpati N. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients. Liver Int. 2018;38(1):38–49
doi: 10.1111/liv.13475
Vyas AK, Negi P, Patra S, Maras JS, Ramakrishna G, Sarin SK, et al. Maternal immunity influences vertical transmission of hepatitis B to newborns. Hepatol Commun. 2019;3:795–811
doi: 10.1002/hep4.1351
Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology. 2013;57:37–45
doi: 10.1002/hep.25988
Wang J, He Y, Jin D, Liu J, Zheng J, Yuan N, et al. No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg. Infect Dis (Lond). 2017;49:576–583
doi: 10.1080/23744235.2017.1292541
Cao M, Wu Y, Wen S, Pan Y, Wang C, Zhang X, et al. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in [infants with HLA-II risk genotype of HBsAg positive mothers. Infect Genet Evol. 2018;63:243–248
doi: 10.1016/j.meegid.2018.06.006
Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg− mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70:396–404
doi: 10.1093/jac/dku404
Yue Y, Meng J, Zhang S. Mechanism of peripheral blood mononuclear cell invasion by HBV on artificial immunization in newborns. Chin Med J (Engl). 2002;115:1380–1382
Koumbi L, Bertoletti A, Anastasiadou V, Machaira M, Goh W, Papadopoulos NG, et al. Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg−mothers. Cell Mol Immunol. 2010;7:454–458
doi: 10.1038/cmi.2010.34
Carollo M, Palazzo R, Bianco M, Pandolfi E, Chionne P, Fedele G, et al. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Vaccine. 2013;31:506–513
doi: 10.1016/j.vaccine.2012.11.029
Shrivastava S, TrehanPati N, Patra S, Kottilil S, Pande C, Trivedi SS, et al. Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in hepatitis B virus-positive newborns. J Viral Hepat. 2013;20:582–591
doi: 10.1111/jvh.12078
Shrivastava S, TrehanPati N, Kottilil S, Sarin SK. Decline in immature transitional B cells after hepatitis B vaccination in hepatitis B positive newborns. Pediatr Infect Dis J. 2013;32:792–794
doi: 10.1097/INF.0b013e31828df344
Hong M, Sandalova E, Low D, Gehring AJ, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588
doi: 10.1038/ncomms7588
Unal C, Tanacan A, Ziyadova G, Fadiloglu E, Beksac MS. Effect of viral load on pregnancy outcomes in chronic hepatitis B infection. J Obstet Gynaecol Res. 2019;45(9):1837–1842
doi: 10.1111/jog.14065
Cui AM, Cheng XY, Shao JG, Li HB, Wang XL, Shen Y, et al. Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study. BMC Pregnancy Childbirth. 2016;16:87
doi: 10.1186/s12884-016-0884-1
Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010;30(5):765–770
doi: 10.1111/j.1478-3231.2010.02218.x
Salemi JL, Whiteman VE, August EM, Chandler K, Mbah AK, Salihu HM. Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat. 2014;21(11):e144–e153
doi: 10.1111/jvh.12250
Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011;31(8):1163–1170
doi: 10.1111/j.1478-3231.2011.02556.x
Bajema KL, Stankiewicz Karita HC, Tenforde MW, Hawes SE, Heffron R. Maternal hepatitis B infection and pregnancy outcomes in the united states: a population-based cohort study. Open Forum Infect Dis. 2018;5(6):ofy134
doi: 10.1093/ofid/ofy134
Tan J, Mao X, Zhang G, Wang W, Pan T, Liu X, et al. Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. J Viral Hepat. 2018;25(11):1372–1383
doi: 10.1111/jvh.12964
Leng J, Zhang C, Wang P, Li N, Li W, Liu H, et al. Plasma levels of alanine aminotransferase in the first trimester identify high risk chinese women for gestational diabetes. Sci Rep. 2016;6:27291
doi: 10.1038/srep27291
Huang X, Tan H, Li X, Zhou S, Wen SW, Luo M. Maternal chronic HBV infection would not increase the risk of pregnancy-induced hypertension—results from pregnancy cohort in Liuyang rural China. PLoS ONE. 2014;9(12):e114248
doi: 10.1371/journal.pone.0114248
Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005;43(5):771–775
doi: 10.1016/j.jhep.2005.05.023
Huang QT, Chen JH, Zhong M, Hang LI, Wei SS, Yu YH. Chronic hepatitis B infection is associated with decreased risk of preeclampsia: a meta-analysis of observational studies. Cell Physiol Biochem. 2016;38(5):1860–1868
doi: 10.1159/000445548
Huang QT, Wei SS, Zhong M, Hang LL, Xu YY, Cai GX, et al. Chronic hepatitis B infection and risk of preterm labor: a meta-analysis of observational studies. J Clin Virol. 2014;61(1):3–8
doi: 10.1016/j.jcv.2014.06.006
Luo LL, Wu JL, Qu Y, Li J, Pan LL, Li DY, et al. Association between maternal HBsAg carrier status and neonatal adverse outcomes: meta-analysis. J Matern Fetal Neonatal Med. 2015;28(11):1308–1317
doi: 10.3109/14767058.2014.953475
Zhuang X, Cui AM, Wang Q, Cheng XY, Shen Y, Cai WH, et al. Liver dysfunction during pregnancy and its association of with preterm birth in china: a prospective cohort study. EBioMedicine. 2017;26:152–156
doi: 10.1016/j.ebiom.2017.11.014
Tan J, Liu X, Mao X, Yu J, Chen M, Li Y, et al. HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepat. 2016;23(10):812–819
doi: 10.1111/jvh.12545
Cai Q, Liu H, Han W, Liu L, Xu Y, He Y, et al. Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis. J Viral Hepat. 2019;26(8):1011–1018
Lao TT. Hepatitis B—chronic carrier status and pregnancy outcomes: an obstetric perspective. Best Pract Res Clin Obstet Gynaecol. 2020;68:66–77
doi: 10.1016/j.bpobgyn.2020.03.006
Xiong Y, Liu C, Huang S, Wang J, Qi Y, Yao G, et al. Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: a population-based study. J Viral Hepat. 2021;28(4):613–620
doi: 10.1111/jvh.13472
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int. 2018;38:813–820
doi: 10.1111/liv.13594
Li L, Zou H, Xu M, Li S, Zhu Y, Zheng S, et al. Risk factors related to postpartum hepatic inflammation in pregnant women with chronic hepatitis B. J Int Med Res. 2020;48:300060520966439
Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut. 2015;64:1810–1815
doi: 10.1136/gutjnl-2014-308211
Wang S, Xiong H, Luo C, Zhao H, Fan Y, Zhang T, et al. Acute-on-chronic liver failure in pregnant patients with chronic hepatitis B: a retrospective observational case series study. Gastroenterol Res Pract. 2020;2020:9831687
Lee JC, Li PH, Mok TY, You SH, Hung HC, Lee CF, et al. Acute exacerbation of hepatitis B with hepatic failure during the first trimester of pregnancy: delivery of a healthy term baby after liver transplantation. Hepatol Res. 2020;50:1386–1390
doi: 10.1111/hepr.13569
The antiretroviral pregnancy registry. Available from: URL: http://www.apregistry.com
Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol. 2015;21(18):5524–5531
doi: 10.3748/wjg.v21.i18.5524
Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–2334
doi: 10.1056/NEJMoa1508660
Tacke F, Kroy DC. Treatment for hepatitis B in patients with drug resistance. Ann Transl Med. 2016;4(18):334
doi: 10.21037/atm.2016.09.19
Wong GL, Seto WK, Wong VW, Yuen MF, Chan HL. Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B. Aliment Pharmacol Ther. 2018;47(6):730–737
doi: 10.1111/apt.14497
Zhou Y, Hu Y, Liu X, Yang H. CSOG MFM committee guideline: management of hepatitis B during pregnancy and prevention of mother-to-child transmission of hepatitis B virus. Matern Fetal Med. 2021;3(1):7–17
doi: 10.1097/FM9.0000000000000087
Charlton MR, Alam A, Shukla A, et al. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol. 2020;55(9):811–823
doi: 10.1007/s00535-020-01698-4
Seto WK, Hui AJ, Wong VW, Wong GL, Liu KS, Lai CL, et al. Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study. Gut. 2015;64:667–672
doi: 10.1136/gutjnl-2014-307237
Kim HY, Choi JY, Park CH, Jang JW, Kim CW, Bae SH, et al. Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus. J Clin Virol. 2013;56:299–305
doi: 10.1016/j.jcv.2012.11.019
Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau DT, et al. Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B. J Clin Gastroenterol. 2018;52:255–261
doi: 10.1097/MCG.0000000000000822
ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat. 2008;15:37–41
Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther. 2009;29:755–764
doi: 10.1111/j.1365-2036.2009.03932.x
Joshi SS, Wong D, Castillo E, Swain MG, Coffin CS. Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease. Am J Reprod Immunol. 2017;78:e12707
doi: 10.1111/aji.12707
Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int. 2010;30:275–283
doi: 10.1111/j.1478-3231.2009.02153.x
Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, et al. Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B. Am J Gastroenterol. 2016;111:1410–1415
doi: 10.1038/ajg.2016.296
Samadi Kochaksaraei G, Castillo E, Osman M, Simmonds K, Scott AN, Oshiomogho JI, et al. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region. J Viral Hepat. 2016;23:15–22
doi: 10.1111/jvh.12436
Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19:122–134
doi: 10.1002/lt.23574
Aggarwal N, Sawnhey H, Suril V, Vasishta K, Jha M, Dhiman RK. Pregnancy and cirrhosis of the liver. Aust N Z J Obstet Gynaecol. 1999;39:503–506
doi: 10.1111/j.1479-828X.1999.tb03145.x
Westbrook RH, Yeoman AD, O’Grady JG, Harrison PM, Devlin J, Heneghan MA. Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol. 2011;9:694–699
doi: 10.1016/j.cgh.2011.03.036
Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008;14:1081–1091
doi: 10.1002/lt.21572
Cheng YS. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol. 1977;128:812–822
doi: 10.1016/0002-9378(77)90727-X
Rasheed SM, Abdel Monem AM, Abd Ellah AH, Abdel Fattah MS. Prognosis and determinants of pregnancy outcome among patients with post-hepatitis liver cirrhosis. Int J Gynaecol Obstet. 2013;121:247–251
doi: 10.1016/j.ijgo.2012.12.020
Hay JE. Liver disease in pregnancy. Hepatology. 2008;47:1067–1076
doi: 10.1002/hep.22130
Allen AM, Hay JE. Review article: the management of cirrhosis in women. Aliment Pharmacol Ther. 2014;40:1146–1154
doi: 10.1111/apt.12974
Pillai AK, Joseph AM, Reddick M, Toomay S, Kalva S. Intravascular US-guided transjugular intrahepatic portosystemic shunt creation in a second-trimester pregnancy to prophylactically decompress abdominal wall varices before cesarean section. J Vasc Interv Radiol. 2014;25:481–483
doi: 10.1016/j.jvir.2013.11.032
Lelei-Mailu FJ, Mariara CM. Pregnancy in a patient with portal hypertension secondary to liver cirrhosis. BMJ Case Rep. 2018;2018:bcr2017223076
doi: 10.1136/bcr-2017-223076
Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773–781
doi: 10.1053/j.gastro.2011.12.035
Cheung KW, Seto MTY, Kan ASY, Wong D, Kou KO, So PL, et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin Gastroenterol Hepatol. 2018;16(1):144–145
doi: 10.1016/j.cgh.2017.07.013
Cheung KW, Lao TT. Hepatitis B—vertical transmission and the prevention of mother-to-child transmission. Best Pract Res Clin Obstet Gynaecol. 2020;68:78–88
doi: 10.1016/j.bpobgyn.2020.02.014
Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective, observational study. Clin Infect Dis. 2021. https://doi.org/10.1093/cid/ciaa1939
doi: 10.1093/cid/ciaa1939
Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med. 2018;378(10):911–923
doi: 10.1056/NEJMoa1708131
Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. J Virol Methods. 1987;17(1–2):69–79
doi: 10.1016/0166-0934(87)90070-X
Pan CQ, Duan ZP, Bhamidimarri KR, Zou HB, Liang XF, Li J, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10(5):452–459
doi: 10.1016/j.cgh.2011.10.041
Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099–1102
doi: 10.1016/S0140-6736(83)90624-4
Zhang L, Gui XE, Wang B, Fan JY, Cao Q, Mullane K, et al. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis. 2016;16(1):408
doi: 10.1186/s12879-016-1754-1
Liu J, Xu B, Chen T, Chen J, Feng J, Xu C, et al. Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig Liver Dis. 2019;51(6):864–869
doi: 10.1016/j.dld.2018.11.003
Schweitzer IL. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci. 1975;270(2):287–291
doi: 10.1097/00000441-197509000-00008
Goudeau A, Yvonnet B, Lesage G, Barin F, Denis F, Coursaget P, et al. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet. 1983;2(8359):1103–1104
doi: 10.1016/S0140-6736(83)90625-6
Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr. 1987;111(6 Pt 1):877–881
doi: 10.1016/S0022-3476(87)80210-X
Tse K, Siu SL, Yip KT, Chan SM, Que TL, Lui WY, et al. Immuno-prophylaxis of babies borne to hepatitis B carrier mothers. Hong Kong Med J. 2006;12(5):368–374
Shikata T, Karasawa T, Abe K. Two distinct types of hepatitis in experimental hepatitis B virus infection. Am J Pathol. 1980;99(2):353–368
Masuzaki H, Miura K, Miura S, Yoshiura K, Mapendano CK, Nakayama D, et al. Labor increases maternal DNA contamination in cord blood. Clin Chem. 2004;50(9):1709–1711
doi: 10.1373/clinchem.2004.036517
Merrill DA, Dubois RS, Kohler PF. Neonatal onset of the hepatitis-associated-antigen carrier state. N Engl J Med. 1972;287(25):1280–1282
doi: 10.1056/NEJM197212212872506
Lu Y, Zhu FC, Liu JX, Zhai XJ, Chang ZJ, Yan L, et al. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: a large prospective cohort study in China. Vaccine. 2017;35(48 Pt B):6627–6633
doi: 10.1016/j.vaccine.2017.10.032
Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. World Health Organization, Geneva. 2020. Licence: CC BY-NC-SA 3.0 IGO
Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599
doi: 10.1002/hep.29800
Zhou YH. Issues meriting further study in preventing mother-to-infant transmission of hepatitis B by antiviral therapy during pregnancy. Matern Fetal Med. 2019;1(1):42–47
doi: 10.1097/FM9.0000000000000012
Hu Y, Zhang S, Luo C, Liu Q, Zhou YH. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infect Dis. 2012;12:221
doi: 10.1186/1471-2334-12-221
Wang F, Zheng H, Zhang G, Ding Z, Li F, Zhong G, et al. Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China. Hum Vaccin Immunother. 2015;11(8):2061–2067
doi: 10.1080/21645515.2015.1023972
Huang H, Xu C, Liu L, Chen L, Zhu X, Chen J, et al. Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa898
doi: 10.1093/cid/ciaa898
Sun KX, Li J, Zhu FC, Liu JX, Li RC, Zhai XJ, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine. 2012;30(36):5335–5340
doi: 10.1016/j.vaccine.2012.06.036
Wen WH, Huang CW, Chie WC, Yeung CY, Zhao LL, Lin WT, et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology. 2016;64(5):1451–1461
doi: 10.1002/hep.28589
Thilakanathan C, Wark G, Maley M, Davison S, Lawler J, Lee A, et al. Mother-to-child transmission of hepatitis B: examining viral cut-offs, maternal HBsAg serology and infant testing. Liver Int. 2018;38(7):1212–1219
doi: 10.1111/liv.13736
Xiao Y, Sun K, Duan Z, Liu Z, Li Y, Yan L, et al. Quasispecies characteristic in “a” determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study. Gut. 2020;69(5):933–941
doi: 10.1136/gutjnl-2019-318278
Epidemiology of vaccine preventable diseases. The pink book course textbook, 13th edition. Atlanta (GA): Centers for Disease Control and Prevention. 2015. ( https://www.cdc.gov/vaccines/pubs/pinkbook/ hepb.html)
Hepatitis B vaccines: WHO position paper—July 2017. Weekly epidemiological record. 2017; 92(27):369–92. http://www.who.int/immunization/policy/position_papers/hepatitis_b/en/
Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94–98
doi: 10.1093/oxfordjournals.aje.a112370
Linder N, Vishne TH, Levin E, Handsher R, Fink-Kremer I, Waldman D, et al. Hepatitis B vaccination: long term follow-up of the immune response of preterm infants and comparison of two vaccination protocols. Infection. 2002;30:136–139
doi: 10.1007/s15010-002-2068-3
Saari TN, American Academy of Pediatrics-Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. Pediatrics. 2003;112:193–198
doi: 10.1542/peds.112.1.193
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332:328–336
doi: 10.1136/bmj.38719.435833.7C
Isaacs D, Kilham HA, Alexander S, Wood N, Buckmaster A, Royle J. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine. 2011;29(37):6159–6162
doi: 10.1016/j.vaccine.2011.06.065
Fu S, Yao NJ, Feng YL, Li J, Wu YC, Tian Z, et al. The efficacy of two different dosages hepatitis B immunoglobulin in interrupting mother-to-infant transmission of hepatitis B virus: a systematic review and meta-analysis. J Hepatol. 2019;70:E124
Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin inneonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70:396–404
doi: 10.1093/jac/dku404
Milne A, West DJ, Chinh DV, Moyes CD, Poerschke G. Field evaluation ofthe efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol. 2002;67:327–333
doi: 10.1002/jmv.10071
Segeral O, Dim B, Durier C et al. Immunoglobulin-free alternative strategy to prevent HBV mother to child transmission in Cambodia: preliminary results of the ANRS 12345 TA PROHM study. EASL International Liver Congress, June 23–26, 2021. Abstract OS-865
Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70–84
doi: 10.1016/S1473-3099(20)30586-7
Ségéral O, N’Diaye DS, Prak S, Nouhin J, Chhun S, Khamduang W, et al. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. J Clin Virol. 2018;109:29–34
doi: 10.1016/j.jcv.2018.10.007
Seck A, Ndiaye F, Maylin S, Ndiaye B, Simon F, Funk AL, et al. Poor sensitivity of commercial rapid diagnostic tests for hepatitis B e antigen in Senegal, West Africa. Am J Trop Med Hyg. 2018;99(2):428–434
doi: 10.4269/ajtmh.18-0116
Segeral O, Dim B, Durier C, Prak S, Chhim K, Vong C, et al. Hepatitis B e antigen (HBeAg) rapid test and alanine aminotransferase level-based algorithm to identify pregnant women at risk of HBV mother-to-child transmission: the ANRS 12345 TA PROHM study. Clin Infect Dis. 2020;71(10):e587–e593
doi: 10.1093/cid/ciaa282
Wu Y, Liu J, Feng Y, Fu S, Ji F, Ge L, et al. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis. Hepatol Int. 2020;14:180–189
doi: 10.1007/s12072-020-10026-0
Yi W, Pan CQ, Li MH, et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. Am J Gastroenterol. 2018;113(5):686–693
doi: 10.1038/s41395-018-0010-2
Zhao Y, Feng Y, Wu Y, Ji F, Chen T. Hepatic flare after antiviral treatment withdraw in post-partum for pregnancy of chronic hepatitis B viral infection: a pairwise and Bayesian network meta-analysis. J Hepatol. 2019;70:E127
doi: 10.1016/S0618-8278(19)30224-5
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98
doi: 10.1007/s12072-015-9675-4
Wang XX, Lu JF, Wu YL, Ma LN, Jin Y, Cao ZH, et al. Clinical study on liver function, virology, serological changes and the safety of drug withdrawal in pregnant women who are chronic HBV carriers during pregnancy and postpartum. Zhonghua Gan Zang Bing Za Zhi. 2019;27(4):261–266 (Chinese)
Liu J, Wang J, Jin D, Qi C, Yan T, Cao F, et al. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus. J Gastroenterol Hepatol. 2017;32(1):177–183
doi: 10.1111/jgh.13436
Wen WH, Chen HL, Shih TT, Wu JF, Ni YH, Lee CN, et al. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate. J Hepatol. 2020;72(6):1082–1087
doi: 10.1016/j.jhep.2020.01.021
Yi W, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2014;60:523–529
doi: 10.1016/j.jhep.2013.11.008
Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19:e18–e25
doi: 10.1111/j.1365-2893.2011.01492.x
Han Z, Zhang Y, Bai X, Yin Y, Xu C, Hou H. Mother-to-child transmission of hepatitis B virus after amniocentesis: a retrospective matched cohort study. Prenat Diagn. 2019;39:431–440
doi: 10.1002/pd.5452
Dionne-Odom J, et al. #38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214:6–14
doi: 10.1016/j.ajog.2015.09.100
Visvanathan K, Dusheiko G, Giles M, Wong ML, Phung N, Walker S, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65(2):340–350
doi: 10.1136/gutjnl-2015-310317
He R, Wen P, Xiong M, Fan Z, Li F, Luo D, et al. Cesarean section in reducing mother-to-child HBV transmission: a meta-analysis. J Matern Fetal Neonatal Med. 2020;20:1–9
doi: 10.1080/14767058.2020.1819229
Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum Reprod Update. 2000;6:432–441
doi: 10.1093/humupd/6.5.432
Mak JSM, Lao TT. Assisted reproduction in hepatitis carrier couples. Best Pract Res Clin Obstet Gynaecol. 2020;68:103–108
doi: 10.1016/j.bpobgyn.2020.02.013
Nie R, Jin L, Zhang H, Xu B, Chen W, Zhu G. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. Fertil Steril. 2011;95:1667–1671
doi: 10.1016/j.fertnstert.2010.12.043
Hu XL, Zhou XP, Qian YL, Wu GY, Ye YH, Zhu YM. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum Reprod. 2011;26:1860–1867
doi: 10.1093/humrep/der103
Lin J, Sha Y, Qiu P. Effects of hepatitis B virus infection in women with different ovarian reserve on outcomes of in vitro fertilization and embryo transfer. Reprod Contracept. 2017;37:106–111
Shi L, Liu S, Zhao W, Zhou H, Ren W, Shi J. Hepatitis B virus infection reduces fertilization ability during in vitro fertilization and embryo transfer. J Med Virol. 2014;86:1099–1104
doi: 10.1002/jmv.23908
Liu L, Liu Q, Wen Y. Ovarian reserve function in infertile women with HBV infection. J Reprod Med. 2016;25:27–31
Yao N, Ma Y, Wang J, Zhang X, Zhao Y, Chen Y, et al. Role of infertile female chronic hepatitis B virus infection in assisted reproduction and infantile outcomes: a systematic review and meta-analysis. Hepatology. 2019;70:599A
Chen H, Ge H-S, Lv J-Q, Wu X-M, Xi H-T, Huang J-Y, et al. Chronic hepatitis B virus infection in women is not associated with IVF/ICSI outcomes. Arch Gynecol Obstet. 2014;289:213–217
doi: 10.1007/s00404-013-2975-9
Lee VCY, Ng EHY, Yeung WSB, Ho PC. Impact of positive hepatitis B surface antigen on the outcome of IVF treatment. Reprod Biomed Online. 2010;21:712–717
doi: 10.1016/j.rbmo.2010.06.036
Jin L, Nie R, Li Y, Xiao N, Zhu L, Zhu G. Hepatitis B surface antigen in oocytes and embryos may not result in vertical transmission to offspring of hepatitis B virus carriers. Fertil Steril. 2016;105:1010–1013
doi: 10.1016/j.fertnstert.2015.12.008
Nie R, Wang M, Liao T, Qian K, Zhu G, Jin L. Assisted conception does not increase the risk for mother-to-child transmission of hepatitis B virus, compared with natural conception: a prospective cohort study. Fertil Steril. 2019;111:348–356
doi: 10.1016/j.fertnstert.2018.10.021
Kang X, Xie Q, Zhou X, Li F, Huang J, Liu D, et al. Effects of hepatitis B virus S protein exposure on sperm membrane integrity and functions. PLoS ONE. 2012;7:e33471
doi: 10.1371/journal.pone.0033471
Zhou X-P, Hu X-L, Zhu Y-M, Qu F, Sun S-J, Qian Y-L. Comparison of semen quality and outcome of assisted reproductive techniques in Chinese men with and without hepatitis B. Asian J Androl. 2011;13:465–469
doi: 10.1038/aja.2010.164
Bu Z, Kong H, Li J, Wang F, Guo Y, Su Y, et al. Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation. Int J Clin Exp Med. 2014;7:1860–1866
Huang J-M, Huang T-H, Qiu H-Y, Fang X-W, Zhuang T-G, Liu H-X, et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastroenterol. 2003;9:736–740
doi: 10.3748/wjg.v9.i4.736
Ali BA, Huang T-H, Salem H-H, Xie Q-D. Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome. Asian J Androl. 2006;8:273–279
doi: 10.1111/j.1745-7262.2006.00141.x
Qx C, Yy Z. Is hepatitis B virus transmitted via the male germ line? A seroepidemiological study in fetuses [Internet]. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. Int J Infect Dis. 2013. Available from: https://pubmed.ncbi.nlm.nih.gov/23154176/
Practice Committee of the American Society for Reproductive Medicine. Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Fertil Steril. 2020;114:1158–1164
doi: 10.1016/j.fertnstert.2020.09.133
Cobo A, Bellver J, de los Santos MJ, Remohí J. Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles. Fertil Steril. 2012;97:74–8.
World Health Organization. Hepatitis B vaccines WHO position paper. Weekly Epidemiol Rec. 2009;84:405–420
Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1–31
Tan KL, Goh KT, Oon CJ, Chan SH. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization. JAMA. 1994;271:859–861
doi: 10.1001/jama.1994.03510350069039
Kramer MS, Aboud F, Mironova E, Vanilovich I, Platt RW, Matush L, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry. 2008;65:578–584
doi: 10.1001/archpsyc.65.5.578
Koletzko B, von Kries R, Closa R, Escribano J, Scaglioni S, Giovannini M, et al. Can infant feeding choices modulate later obesity risk? Am J Clin Nutr. 2009;89:1502S-1508S
doi: 10.3945/ajcn.2009.27113D
Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, et al. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat. 2007;102:365–374
doi: 10.1007/s10549-006-9343-4
Petrova M, Kamburov V. Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol. 2010;16(40):5042–5046
doi: 10.3748/wjg.v16.i40.5042
Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS. Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr. 1993;17:207–210
doi: 10.1097/00005176-199308000-00014
Yang D, Li Y, Song J. Significance of detection of HBV-DNA and CMV-DNA by polymerase chain reaction in screening mothers’ milk. Hunan Yikedaxue Xuebao. 1999;24:44–46
Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med. 2011;165(9):837–846
doi: 10.1001/archpediatrics.2011.72
Egashira M, Takayanagi T, Moriuchi M, Moriuchi H. Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis? Acta Paediatr. 2007;96:1242–1244
doi: 10.1111/j.1651-2227.2007.00393.x
Li S, Zhou H, Huang G, Liu N. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Med Microbiol Immunol. 2009;198:19–25
doi: 10.1007/s00430-008-0100-7
Thea DM, Aldrovandi G, Kankasa C, Kasonde P, Decker WD, Semrau K, et al. Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS. 2006;20:1539–1547
doi: 10.1097/01.aids.0000237370.49241.dc
Shapiro RL, Holland DT, Capparelli E, et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis. 2005;192:720–727
doi: 10.1086/432483
Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, et al. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS. 2008;22:1633–1640
doi: 10.1097/QAD.0b013e328307a029
Palombi L, Pirillo MF, Marchei E, Jere H, Sagno JB, Luhanga R, et al. Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the option B-plus approach in Malawi. J Antimicrob Chemother. 2016;71:1027–1030
doi: 10.1093/jac/dkv435
Waitt C, Olagunju A, Nakalema S, Kyohaire I, Owen A, Lamorde M, et al. Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs. J Antimicrob Chemother. 2018;73:1013–1019
doi: 10.1093/jac/dkx507
Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, et al. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015;16:502–511
doi: 10.1111/hiv.12252
Hu X, Wang L, Xu F. Guides concerning tenofovir exposure via breastfeeding: a comparison of drug dosages by developmental stage. Int J Infect Dis. 2019;87:8–12
doi: 10.1016/j.ijid.2019.07.023
Ghazinyan HL. Hepatitis B and Pregnanacy. Blood. 2015;2(20):46–47
Hepatitis B. Vaccines. Wkly Epidemiol Rec. 2009;84(40):405–419
Hepatitis B. vaccines: WHO position paper, July 2017. Wkly Epidemiol Rec. 2017;92(27):369–392
Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto C, et al. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Vaccine. 2019;37(35):5059–5066
doi: 10.1016/j.vaccine.2019.06.073
Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis. 2015;15(8):981–985
doi: 10.1016/S1473-3099(15)00158-9
WHO guidelines on hepatitis B and C testing. World Health Organization, Geneva. 2017. Licence: CC BY-NC-SA 3.0 IGO
Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis. 2012;9(12):131
doi: 10.1186/1471-2334-12-131
Allison RD, Patel MK, Tohme RA. Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth. Vaccine. 2017;35:4094–4098
doi: 10.1016/j.vaccine.2017.06.051
Petit D, Tevi-Benissan C, Woodring J, Hennessey K, Kahn A-L. Countries’ interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions. Vaccine. 2017;35:6866–6871
doi: 10.1016/j.vaccine.2017.10.025
Abravanel F, Lhomme S, Trémeaux P, et al. Performance of the Xpert HBV viral load assay versus the aptima quant assay for quantifying hepatitis B virus DNA. Diagn Microbiol Infect Dis. 2020;96:114946
doi: 10.1016/j.diagmicrobio.2019.114946